Qube Research & Technologies LTD Care Dx, Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Care Dx, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 340,910 shares of CDNA stock, worth $6.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
340,910
Previous 112,984
201.73%
Holding current value
$6.38 Million
Previous $3.53 Million
106.92%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding CDNA
# of Institutions
217Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$98.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$90.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$49.8 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$45.1 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$41.3 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...